Actinium Pharmaceuticals reported $43.9M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Actinium Pharmaceuticals USD 50M 6M Sep/2025
Amgen USD 195.44B 5.55B Jun/2026
Bioline Rx USD 12M 4M Dec/2025
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026